212 related articles for article (PubMed ID: 25382058)
21. Folate-PEG modified poly(2-(2-aminoethoxy)ethoxy)phosphazene/DNA nanoparticles for gene delivery: synthesis, preparation and in vitro transfection efficiency.
Zhang P; Zhang Z; Yang Y; Li Y
Int J Pharm; 2010 Jun; 392(1-2):241-8. PubMed ID: 20298769
[TBL] [Abstract][Full Text] [Related]
22. Low molecular weight polyethylenimine cross-linked by 2-hydroxypropyl-gamma-cyclodextrin coupled to peptide targeting HER2 as a gene delivery vector.
Huang H; Yu H; Tang G; Wang Q; Li J
Biomaterials; 2010 Mar; 31(7):1830-8. PubMed ID: 19942284
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and evaluation of N-(2,3-dihydroxypropyl)-PEIs as efficient vectors for nucleic acids.
Tripathi SK; Yadav S; Gupta KC; Kumar P
Mol Biosyst; 2012 Apr; 8(5):1426-34. PubMed ID: 22419101
[TBL] [Abstract][Full Text] [Related]
24. Effective gene delivery into adipose-derived stem cells: transfection of cells in suspension with the use of a nuclear localization signal peptide-conjugated polyethylenimine.
Park E; Cho HB; Takimoto K
Cytotherapy; 2015 May; 17(5):536-42. PubMed ID: 25618562
[TBL] [Abstract][Full Text] [Related]
25. Coupling of importin beta binding peptide on plasmid DNA: transfection efficiency is increased by modification of lipoplex's physico-chemical properties.
Carrière M; Escriou V; Savarin A; Scherman D
BMC Biotechnol; 2003 Sep; 3():14. PubMed ID: 12969505
[TBL] [Abstract][Full Text] [Related]
26. Cell-surface glycosaminoglycans inhibit intranuclear uptake but promote post-nuclear processes of polyamidoamine dendrimer-pDNA transfection.
Ziraksaz Z; Nomani A; Ruponen M; Soleimani M; Tabbakhian M; Haririan I
Eur J Pharm Sci; 2013 Jan; 48(1-2):55-63. PubMed ID: 23131796
[TBL] [Abstract][Full Text] [Related]
27. CXCR4 transfection of cord blood mesenchymal stromal cells with the use of cationic liposome enhances their migration toward stromal cell-derived factor-1.
Marquez-Curtis LA; Gul-Uludag H; Xu P; Chen J; Janowska-Wieczorek A
Cytotherapy; 2013 Jul; 15(7):840-9. PubMed ID: 23623275
[TBL] [Abstract][Full Text] [Related]
28. Differential endosomal pathways for radically modified peptide vectors.
Arukuusk P; Pärnaste L; Margus H; Eriksson NK; Vasconcelos L; Padari K; Pooga M; Langel U
Bioconjug Chem; 2013 Oct; 24(10):1721-32. PubMed ID: 23981119
[TBL] [Abstract][Full Text] [Related]
29. PEGylated poly(2-(dimethylamino) ethyl methacrylate)/DNA polyplex micelles decorated with phage-displayed TGN peptide for brain-targeted gene delivery.
Qian Y; Zha Y; Feng B; Pang Z; Zhang B; Sun X; Ren J; Zhang C; Shao X; Zhang Q; Jiang X
Biomaterials; 2013 Mar; 34(8):2117-29. PubMed ID: 23245924
[TBL] [Abstract][Full Text] [Related]
30. Hydrophobic and electrostatic interactions between cell penetrating peptides and plasmid DNA are important for stable non-covalent complexation and intracellular delivery.
Upadhya A; Sangave PC
J Pept Sci; 2016 Oct; 22(10):647-659. PubMed ID: 27723187
[TBL] [Abstract][Full Text] [Related]
31. Targeting human epidermal growth factor receptor 2 by a cell-penetrating peptide-affibody bioconjugate.
Govindarajan S; Sivakumar J; Garimidi P; Rangaraj N; Kumar JM; Rao NM; Gopal V
Biomaterials; 2012 Mar; 33(8):2570-82. PubMed ID: 22192536
[TBL] [Abstract][Full Text] [Related]
32. Transferrin- and folate-modified, double-targeted nanocarriers for gene delivery.
Jing F; Li D; Xu W; Liu Y; Wang K; Sui Z
Pharm Biol; 2014 May; 52(5):570-4. PubMed ID: 24256214
[TBL] [Abstract][Full Text] [Related]
33. S4(13)-PV cell penetrating peptide and cationic liposomes act synergistically to mediate intracellular delivery of plasmid DNA.
Trabulo S; Mano M; Faneca H; Cardoso AL; Duarte S; Henriques A; Paiva A; Gomes P; Simões S; de Lima MC
J Gene Med; 2008 Nov; 10(11):1210-22. PubMed ID: 18729238
[TBL] [Abstract][Full Text] [Related]
34. Delivery of nucleic acids with a stearylated (RxR)4 peptide using a non-covalent co-incubation strategy.
Lehto T; Abes R; Oskolkov N; Suhorutsenko J; Copolovici DM; Mäger I; Viola JR; Simonson OE; Ezzat K; Guterstam P; Eriste E; Smith CI; Lebleu B; Samir El Andaloussi ; Langel U
J Control Release; 2010 Jan; 141(1):42-51. PubMed ID: 19744531
[TBL] [Abstract][Full Text] [Related]
35. Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells.
Su L; Zhang J; Xu H; Wang Y; Chu Y; Liu R; Xiong S
Clin Cancer Res; 2005 Dec; 11(23):8273-80. PubMed ID: 16322285
[TBL] [Abstract][Full Text] [Related]
36. Self-assembled ternary complexes of plasmid DNA, low molecular weight polyethylenimine and targeting peptide for nonviral gene delivery into neurons.
Zeng J; Wang X; Wang S
Biomaterials; 2007 Mar; 28(7):1443-51. PubMed ID: 17156837
[TBL] [Abstract][Full Text] [Related]
37. Targeted liposomes to deliver DNA to cells expressing 5-HT receptors.
Gopal V; Xavier J; Dar GH; Jafurulla M; Chattopadhyay A; Rao NM
Int J Pharm; 2011 Oct; 419(1-2):347-54. PubMed ID: 21855617
[TBL] [Abstract][Full Text] [Related]
38. Development of peptide-targeted lipoplexes to CXCR4-expressing rat glioma cells and rat proliferating endothelial cells.
Driessen WH; Fujii N; Tamamura H; Sullivan SM
Mol Ther; 2008 Mar; 16(3):516-24. PubMed ID: 18195720
[TBL] [Abstract][Full Text] [Related]
39. AMD3100 conjugates as components of targeted nonviral gene delivery systems: synthesis and in vitro transfection efficiency of CXCR4-expressing cells.
Le Bon B; Van Craynest N; Daoudi JM; Di Giorgio C; Domb AJ; Vierling P
Bioconjug Chem; 2004; 15(2):413-23. PubMed ID: 15025540
[TBL] [Abstract][Full Text] [Related]
40. Design and evaluation of a CXCR4 targeting peptide 4DV3 as an HIV entry inhibitor and a ligand for targeted drug delivery.
Heon Lee I; Palombo MS; Zhang X; Szekely Z; Sinko PJ
Eur J Pharm Biopharm; 2019 May; 138():11-22. PubMed ID: 29894816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
